Hello! You're looking at a policy document report on Overton

We track government policy, guidelines, think tank research, working papers and more to help our customers see the impact and influence of their work.

If you fund, produce or manage research or work to influence policy, we'd love to talk. Learn more on our homepage.

Interim guidance for collection and submission of postmortem specimens from deceased persons under investigation (PUI) for COVID-19, February 2020

Flag for USA Centers for Disease Control and Prevention (CDC) on March 14th 2020

Topics in this document

Related SDGs

Citations

Cited by 27 other policy documents (all of them are from other policy sources)
 

Everything cited by this document (explore the cited policy documents)

See details
Evaluating and testing persons for coronavirus disease 2019 (COVID-19)
Centers for Disease Control and Prevention (CDC)
CDC has updated its guidance on what specimens to collect when testing for COVID-19. The latest guidance is available online at Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19). https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html
On page 1
See details
The Centers for Disease Control and Prevention
Centers for Disease Control and Prevention (CDC)
This interim guidance is based on what is currently known about COVID-19. The Centers for Disease Control and Prevention (CDC) will update this interim guidance as needed and as additional information becomes available. https://www.cdc.gov/coronavirus/2019-ncov/about/index.html
On page 1
See details
Interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)
Centers for Disease Control and Prevention (CDC)
In addition to postmortem specimens, submission of any remaining clinical specimens (e.g., NP swab, OP swab, sputu serum, stool) that may have been collected prior to death is recommended. Please refer to Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons Under Investigation (PUIs) for Coronavirus Disease 2019 (COVID-19) for more information. https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html
On page 2
See details
Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)
Centers for Disease Control and Prevention (CDC)
Implementing proper biosafety and infection control practices is critical when collecting specimens. Please refer to Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19) for additional information. https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html
On page 4